More scientific evidence on GastroPanel® test – the test

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
More scientific evidence on GastroPanel® test – the test predicts gastric cancer risk even at 15-year follow-up

B iohit Oyj Press Release May 23, 2016 at 01:45 pm local time (EEST) 

Low Pepsinogen I level diagnosed with GastroPanel® test predicts the risk for stomach cancer even years in advance. The result is evident in two separate recent studies among Asian and Caucasian population, where the subjects were followed-up for several years after GastroPanel® testing. Low Pepsinogen I level in the blood sample accompanied by high Gastrin-17 level, is a sign of atrophic gastritis of the corpus. The latter is known to be a risk factor for gastric cancer. The long-term predictive value of GastroPanel® test as a predictor of this risk has not been previously confirmed in a Caucasian population.  

Biohit GastroPanel®-test consists of four biomarkers: Pepsinogen I and II (PGI, PGII), Gastrin-17 (G-17) and  Helicobacter pylori  -antibodies. The test is intended for diagnosis of Helicobacter pylori infection in dyspeptic patients and in health controls as well as for early detection and screening of atrophic gastritis and all associated risks caused by this infection or autoimmune disease. The test also reveals high acid output and its potential sequels. Asymptomatic atrophic gastritis, high acid output or symptomatic Helicobacter pylori infection are indications of gastroscopic examination (see Additional Information).

The two studies were conducted among Caucasian and Asian population

The first study was conducted among Caucasian population in Novosibirsk region in Western Siberia. A cohort of 9360 people was included in the study, derived from the local population, and the group was followed-up for 7-10 years to estimate the risk of gastric cancer. To calculate the predictive value of GastroPanel® test, 2 age- and sex-matched controls were selected for each gastric cancer patient.  Blood samples taken from all subjects at the beginning of the follow-up were analysed with GastroPanel® test.

The study conducted in Taiwan had a very similar study design. The cohort size was 3514 and the follow-up time was up to 15 years (1995–2010). During the follow-up, 14 persons died of gastric cancer. In a multivariate model adjusted for several variables, low PGI was the best predictor of gastric cancer. Risk ratio (RR=3.24) was almost identical with the risk ratio (RR=2.9) obtained for PGI/PGII ratio in the Novosibirsk study.

Chief Medical Director Kari Syrjänen, Biohit Oyj: ‘These two important studies based on a long-term follow-up show consistently that the markers of GastroPanel® test indicating atrophic gastritis are highly reliable  predictors of gastric cancer risk even at a 15-year time span. Similarly, the long-term negative predictive value of normal GastroPanel® test result is over 95 %, which helps identifying the high-risk persons also in a population-based screening.’

CEO Semi Korpela, Biohit Oyj: ’The two studies provide more convincing evidence that the cost-effective GastroPanel® innovation, providing a lot of information, is, among other things, an excellent test for screening of gastric cancer risk (see Additional Information).’

Articles:

Stomach-specific Biomarkers (GastroPanel) Can Predict the Development of Gastric Cancer in a Caucasian Population: A Longitudinal Nested Case-Control Study in Siberia (Kurilovich et al) Anticancer Research 36: 247-254 (2016).

The Association Between Serum Pepsinogen Testing and Death From Gastric Cancer: A sixteen-Year Population-Based Cohort Study (Lee et al.) Poster presentation at Digestive Disease Week, San Diego, California, May 22, 2016.

Additional information on GastroPanel® test can be found in the attachment

Additional information: CEO Semi Korpela, Biohit Oyj tel. +358 9 773 861 investor.relations@biohit.fi www.biohithealthcare.com

Additional Information.pdf

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit Series B share (BIOBV) is quoted on NASDAQ OMX Helsinki in the Small cap/Healthcare group.   www.biohithealthcare.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Zesty Takes Kubernetes Cost Control Into GPU Territory

Updated Category News Views 88

GPU waste has become the sort of cloud bill nobody wants to explain upstairs. A company buys scarce, expensive accelerators for AI work, then discovers that real workloads do not politely consume resources in neat, permanent blocks. Demand jumps, memory needs shift, and somebody either over-allocates to avoid trouble or under-allocates and gets ugly out-of-memory...

Continue Reading
Chargeback AI Still Has a Costly Last-Mile Problem

Updated Category News Views 41

A corrected headline is a small wrinkle, but the underlying chargeback mess is not. Chargeflow and Juniper Research surveyed 121 senior executives at U.S. and U.K. businesses with at least $100 million in annual gross merchandise value, and the useful takeaway is painfully clear: merchants are putting AI on the label without rebuilding the machinery underneath. That...

Continue Reading
RLX Revenue Soars, but European Margins Need Proof

Updated Category News Views 38

Revenue can wear a fancy suit while earnings arrive in work boots, and RLX Technology's third quarter is exactly that kind of report. The newly consolidated European distribution business pushed third-quarter revenue to RMB1.92 billion, up 69.7% year over year. That is a real jump, not pocket change. But the same acquisition also changed the mix, squeezed the blended...

Continue Reading
Klarna’s Cash Burn Puts Disclosure Questions in Focus

Updated Category News Views 98

A $383 million operating cash drain can turn a growth story sour in a hurry. Klarna Group plc delivered exactly that kind of unpleasant jolt in its third-quarter 2026 report: a net loss of $65 million, or roughly $0.19 per share, alongside negative operating cash flow of $383 million over the first nine months of 2026. The per-share loss landed worse than the $0.13 to...

Continue Reading
COP31 Tests Whether Climate Warnings Move Power Systems

Updated Category News Views 82

A weather alert that never reaches the control room is just expensive wallpaper. That was the useful, unsentimental thread running through a COP31 side event in Ankara on November 13: climate diplomacy is not worth much if grid operators, project owners and financiers do not change what they do when the forecast turns ugly. Implementation Means Changing Operations COP31...

Continue Reading
Vanguard's Digital Win Matters More Than a Trophy

Updated Category News Views 182

A wealth manager’s website rarely earns applause, but a bad one can sure as hell lose trust fast. Vanguard’s move to No. 1 from No. 3 in the 2025 ranking for advised-investor website satisfaction is worth noticing because it hits the unglamorous part of wealth management that clients actually live with: checking accounts, understanding a plan, moving cash, and...

Continue Reading
Retainers Are the Unflashy Finish to Orthodontic Care

Updated Category News Views 98

A straight smile has an inconvenient habit of remembering where it came from. That is the plainspoken point in Dr. Michael McClain’s discussion of retainers after braces or Invisalign: the dramatic part of orthodontic treatment may be over when appliances come off, but the maintenance phase has barely started. It is not glamorous, and plenty of people probably wish it...

Continue Reading
TSA at 25: Security Mission Meets a Tough Travel Reality

Updated Category News Views 111

Twenty-five years after its birth from catastrophe, TSA is still carrying a job nobody should take lightly. The agency marked its anniversary on November 19, 2026, looking back to the September 11, 2001 attacks that led to federalized aviation screening and a permanent reshaping of how Americans move through airports. This is not the sort of milestone that deserves...

Continue Reading
Mindstream’s Jordan AI Campus Faces Its First Real Test

Updated Category News Views 65

Jordan’s AI ambitions just got attached to a very large gas meter. Mindstream Energy has unveiled a plan for an AI-ready data-center campus at Al-Risha in Mafraq Governorate, built around dedicated natural-gas generation rather than a conventional dependence on the utility grid. The headline number is 400 megawatts of eventual capacity. The number that matters first is...

Continue Reading
Automotive Laminates: Small Market, Real EV Leverage

Updated Category News Views 223

Cabin trim has become a surprisingly serious battleground, and that is the whole point of this automotive laminates story. Nobody buys a vehicle because somebody bragged about a multilayer film behind the door panel. Yet the materials under the fingertips, beneath the carpet, and around the dashboard increasingly decide whether an interior feels cheap, quiet, durable, or...

Continue Reading

Top 5 Most Recently Viewed Articles

374Water Takes Major Step Forward in Environmental Solutions

Updated Category News Views 172

374Water Secures Significant Contract for AFFF Destruction In an exciting development, 374Water Inc. (NASDAQ: SCWO) has recently secured a crucial contract to tackle the destruction of Aqueous Film-Forming Foam (AFFF) as part of North Carolina's efforts to manage hazardous materials. This initiative is pivotal in addressing the harmful effects of per- and polyfluoroalkyl...

Continue Reading
Crypto Winter: Bitwise's Hougan on the Bear Phase and Future Hopes

Updated Category News Views 183

Matt Hougan, Chief Investment Officer of Bitwise Asset Management, isn't sugarcoating it—crypto’s in a bear phase. You know this drill; it's like déjà vu from past crypto winters in 2018 and 2022. Traders are feeling that chill already as the market grapples with extreme fear sentiment readings that indicate we might’ve been in this winter longer than most want to...

Continue Reading
Only 41% of Firms Support Women in Tech Hiring Initiatives

Updated Category News Views 207

Understanding the Gender Diversity Gap in Tech Recent findings indicate a substantial gap in gender diversity within the technology sector. A staggering 87 percent of IT professionals recognize this issue, yet only 41 percent of businesses have developed programs to actively recruit more women. This data sheds light on the challenges women face in entering and advancing...

Continue Reading
Parker Barrile Joins Dave as New Chief Product Officer

Updated Category News Views 222

Parker Barrile Joins Dave as Chief Product Officer Los Angeles – In an exciting development for Dave Inc. (Nasdaq: DAVE), a prominent player in the neobank sector, Parker Barrile has been appointed as the Chief Product Officer. This strategic decision is set to take effect soon, marking a pivotal moment in the company’s growth story. Experience and Vision Parker...

Continue Reading
Northern Trust: An In-Depth Analysis Before Earnings Report

Updated Category News Views 216

What to Expect from Northern Trust's Upcoming Earnings Northern Trust (NASDAQ:NTRS) is poised to release its latest quarterly earnings report soon. Investors are eagerly awaiting insights on the company’s financial performance and outlook. Understanding the key metrics and analyst expectations can help guide investment decisions. Current Earnings Expectations Analysts...

Continue Reading